Three Different Approaches to Quantification of Ki-67 Immunohistochemistry in Neuroendocrine Tumours of the Lung and Mediastinum

Pathology - United States
doi 10.1016/j.pathol.2020.01.253
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Proliferative Activity in Human Breast Cancer: Ki-67 Automated Evaluation and the Influence of Different Ki-67 Equivalent Antibodies

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2011English

The Diagnostic Role of P53 and Ki 67 Immunohistochemistry in Evaluation of Urinary Bladder Carcinomas in Egyptian Patients

International Journal of Chinese Medicine
2019English

Ki-67 Index as a Predictor of Response to Y-90 Radioembolization for Neuroendocrine Tumors Metastatic to the Liver

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2017English

Prognostic Implications of P53 Protein, Epidermal Growth Factor Receptor, and Ki-67 Labelling in Brain Tumours

British Journal of Cancer
Cancer ResearchOncology
1992English

Mesenchymal Tumours of the Mediastinum—part II

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2015English

Mesenchymal Tumours of the Mediastinum—part I

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2015English

Correlation Between the Ki-67 Proliferation Index and Response to Radiation Therapy in Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Ki-67 and the Chromosome Periphery Compartment in Mitosis

Trends in Cell Biology
Cell Biology
2017English

Figure 4: Quantification of EdU and Ki-67 Labelling in Human Neural Progenitor Cells in Response to Harmine and Its Functional Analogs.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy